Tom Isaacs

Exenatide and the treatment of patients with Parkinson’s disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Clinical Investigation · 2013 · 494 citations

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Parkinson s Disease · 2014 · 291 citations · Full text

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

Waasila Jassat, Cheryl Cohen, Stefano Tempia et al. · The Lancet HIV · 2021 · 174 citations · Full text

Quantitative home-based assessment of Parkinson’s symptoms: The SENSE-PARK feasibility and usability study

Joaquim J. Ferreira, Catarina Godinho, A. Santos et al. · BMC Neurology · 2015 · 99 citations · Full text

Participatory Design in Parkinson's Research with Focus on the Symptomatic Domains to be Measured

J. Artur Serrano, Frank Larsen, Tom Isaacs et al. · Journal of Parkinson s Disease · 2015 · 34 citations · Full text